Literature DB >> 162925

Invasion of the central nervous system by herpes simplex virus type 1 after subcutaneous inoculation of immunosuppressed mice.

J E Oakes.   

Abstract

Young adult mice given subcutaneous inoculations in the rear footpad with herpes simplex virus type 1 were found to be resistant to infection unless they were immunosuppressed with sublethal doses of irradiation or cyclophosphamide. In these mice, virus multiplied in the sciatic nerve three to four days after inoculation. This development was followed by multiplication of virus in the spinal cord and brain, which caused death of the mice in about eight days. No virus was detected in the blood or liver. Resection of the sciatic nerve significantly increased the number of immunosuppressed mice surviving footpad inoculation. Passive transfer of antibody had no effect on the course of infection. Sublethal doses of irradiation or cyclophosphamide can apparently increase the susceptibility of the central nervous system to invasion of Herpesvirus from extraneural sites of infection by spread along peripheral nerves.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 162925     DOI: 10.1093/infdis/131.1.51

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  12 in total

1.  Role for cell-mediated immunity in the resistance of mice to subcutaneous herpes simplex virus infection.

Authors:  J E Oakes
Journal:  Infect Immun       Date:  1975-07       Impact factor: 3.441

2.  Effect of treatment with 5-ethyl-2'-deoxyuridine on herpes simplex virus encephalitis in normal and immunosuppressed mice.

Authors:  W B Davis; J E Oakes; J A Taylor
Journal:  Antimicrob Agents Chemother       Date:  1978-11       Impact factor: 5.191

3.  Impact of valency of a glycoprotein B-specific monoclonal antibody on neutralization of herpes simplex virus.

Authors:  Adalbert Krawczyk; Jürgen Krauss; Anna M Eis-Hübinger; Martin P Däumer; Robert Schwarzenbacher; Ulf Dittmer; Karl E Schneweis; Dirk Jäger; Michael Roggendorf; Michaela A E Arndt
Journal:  J Virol       Date:  2010-12-01       Impact factor: 5.103

4.  Comparative neurovirulence of herpes simplex virus type 1 strains after peripheral or intracerebral inoculation of BALB/c mice.

Authors:  R D Dix; R R McKendall; J R Baringer
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

5.  Gastrointestinal invasion by herpes simplex virus type 1 inoculated cutaneously into the immunosuppressed mice.

Authors:  H Takase; E Yamamura; Y Murakami; T Ikeuchi; Y Osada
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

6.  Efficacy of herpes simplex virus type 1 immunization in protecting against acute and latent infection by herpes simplex virus type 2 in mice.

Authors:  R R McKendall
Journal:  Infect Immun       Date:  1977-05       Impact factor: 3.441

7.  Antibody-mediated recovery from subcutaneous herpes simplex virus type 2 infection.

Authors:  J E Oakes; H Rosemond-Hornbeak
Journal:  Infect Immun       Date:  1978-08       Impact factor: 3.441

8.  Use of monoclonal antibody directed against herpes simplex virus glycoproteins to protect mice against acute virus-induced neurological disease.

Authors:  R D Dix; L Pereira; J R Baringer
Journal:  Infect Immun       Date:  1981-10       Impact factor: 3.441

9.  Lymphocyte reactivity contributes to protection conferred by specific antibody passively transferred to herpes simplex virus-infected mice.

Authors:  J E Oakes; W B Davis; J A Taylor; W A Weppner
Journal:  Infect Immun       Date:  1980-08       Impact factor: 3.441

10.  Role of Fc fragments in antibody-mediated recovery from ocular and subcutaneous herpes simplex virus infections.

Authors:  J E Oakes; R N Lausch
Journal:  Infect Immun       Date:  1981-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.